- Visibility 2.6k Views
- Downloads 299 Downloads
- Permissions
- DOI 10.18231/j.ijced.89447.1758864688
-
CrossMark
Prolonged high dose daily oral vitamin D3 in the management of psoriasis: A retrospective chart analysis
- Author Details:
-
Renu Mahtani
-
Sudhir Singh *
-
Pradeep MK Nair
-
Satya Prakash Singh
-
Mankul Goyal
Renu Mahtani
Sudhir Singh *
Pradeep MK Nair
Satya Prakash Singh
Background: Autoimmune disorders, particularly psoriasis, are often associated with vitamin D deficiency and vitamin D resistance. Higher daily doses of vitamin D3 are considered effective in overcoming vitamin D resistance and reversing psoriasis symptoms. This study was conducted to evaluate the safety and efficacy of individualized, prolonged high-dose daily oral vitamin D3 therapy in patients with moderate-to-severe psoriasis.
Materials and Methods: In this study, we present data from 95 patients with moderate-to-severe psoriasis who underwent individualized high-dose daily oral vitamin D3 (cholecalciferol) therapy. From this cohort, six representative cases are described in detail to illustrate the approach to personalized dosing and the monitoring process using biochemical markers such as parathyroid hormone (PTH) and ionized calcium. The efficacy of the intervention was assessed using Psoriasis Area and Severity Index (PASI) scores, while safety was evaluated through regular monitoring of serum creatinine and ionized calcium levels. Statistical analyses were conducted to examine the relationship between vitamin D3 dosage, serum 25(OH)D levels, PTH suppression, and clinical improvement.
Results: Significant clinical improvement or remission was noted, without hypercalcemia or toxicity. PTH levels consistently declined in parallel with clinical response, suggesting vitamin D action.
Conclusion: Monitored oral vitamin D3 therapy in higher than supplemental dose, can be a safe and effective treatment for psoriasis.
References
- Dai Q, Zhang Y, Liu Q, Zhang C. Efficacy and safety of vitamin D supplementation on psoriasis: A systematic review and meta- analysis. PLoS ONE. 2023;18(11): e0294239
- Michelle A. Ingram et al. Oral vitamin D3 supplementation for chronic plaque psoriasis: a randomized, double-blind, placebo- controlled trial. J Dermatol Treat. 2018;29(7):648–57.
- Formisano E, Proietti E, Borgarelli C, Pisciotta L. Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(15):3387.
- Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potentials. Front Immunol. 2017:7:697.
- Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky- Kochan C, et al. Vitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A. Mol Cell Biol. 2011;31(17):3653-69.
- Lemke D, Klement RJ, Schweiger F, Schweiger B, Spitz J. Vitamin D Resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol. Front Immunol. 2021:12:655739.
- Carlberg C, Haq A. The concept of the personal vitamin D response index. J Steroid Biochem Mol Biol. 2018;175:12–7. 296 Mahtani et al. / IP Indian Journal of Clinical and Experimental Dermatology 2025;11(3):288-296
- Amon U, Yaguboglu R, Ennis M, Holick MF, Amon J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the “Coimbra Protocol”. Nutrients. Nutrients. 2022;14(8):1575;
- Glade MJ. A 21st century evaluation of the safety of oral vitamin D. Nutrition. 2012;28(4):344–56.
- Finamor DC, Sinigaglia-Coimbra R, Neves LCM, Gutierrez M, Silva JJ, Torres LD, et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013;5(1):222–34.
- Mahtani R, Nair PMK. Daily Oral Vitamin D3 without Concomitant Therapy in the management of Psoriasis: A case series. Clin Immunol Commun. 2022;2:17–22.
- Carlin CS, Feldman SR, Krueger JG, Menter A, Krueger GG. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 2004;50(6):859–66.
- Stanescu AMA, Simionescu AA, Diaconu CC. Oral Vitamin D therapy in patients with Psoriasis. Nutrients. 2021;13(1):163.
- Jarvelin UM, Järvelin JM. Significance of vitamin D responsiveness on the etiology of vitamin D-related diseases. Steroids. 2024;207:109437.
- McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 to 50000 Internation Units a day in long-term hospitalized patients: Insights from a seven-year experience. J Steroid Biochem Mol Biol. 2019;189:228–39.